Abstract: A botanical matrix and a base are disclosed for use in producing vapes. The base includes propanediol, vegetal glycerin and a blend of two or more botanical additives. The propanediol and glycerin may be lab produced for improved consistency. Additional ingredients including active ingredients may be added to the base to produce a vape. The botanical additives provide a base that has a smoother impression and reduces or eliminates throat burn.

Abstract: Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.

Abstract: A personal skincare product that provides cleansing, antiseptic, antibacterial, soothing, moisturizing, protective, and healing benefits to irritated skin and wounds for all ages, particularly for consumers with sensitive and fragile skin like children and the elderly. The personal skincare product comprises a topical antiseptic comprising water, benzalkonium chloride, phenoxyethanol, aloe, liquid coconut, propylene glycol, collagen, polyethylene glycol, sodium benzoate, petrolatum, lanolin, mineral oil, cod liver oil, paraffin, sodium, olive oil, cottonseed oil, vitamin E, and a non-ionic copolymer such as Poloxamer 188 or a combination therefrom.

Abstract: The present disclosure provides for compositions combining Cannabinoid Fractions and Mushroom Extract Fractions for recreational and medicinal uses. The disclosed compositions are useful for treating symptoms of anxiety, stress, pain, and promoting sleep. The pharmaceutical compositions comprise particular cannabinoid ratios and terpene profiles.

Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.

Abstract: A method of topically applying to skin a composition comprising a water soluble Phoenix dactylifera seed extract, an essential oil from the leaves of tea tree, an aqueous Myrothamnus flabellifolia leaf and stem extract, and a saccharide isomerate comprising an exopolysaccharide of Vibrio alginolyticus is disclosed.

Abstract: A composition includes Andrographis paniculata extract at about 20% to about 30% by weight of the total composition; Withania somnifera extract at about 16% to about 24% by weight of the total composition; Moringa oleifera extract at about 24% to about 36% by weight of the total composition; and Ocimum sanctum extract at about 20% to about 30% by weight of the total composition. The composition may be in the form of a capsule, a pill, or a tablet. A method of supporting, maintaining, or improving immunity in a mammal includes administering the composition to a mammal, where upper respiratory tract infection symptoms are reduced, concentration of C-Reactive protein in the blood of the mammal is decreased, or the concentration of Immunoglobulin G in the blood of the mammal is increased. The mammal may be a human. The improved immunity may be to a virus. The improved immunity may be to an upper respiratory tract infection.

Abstract: Films that are mucosally dissolvable, and containing a matrix and one or more active agents from hemp or cannabis within the matrix, are provided. The disclosure also provides methods for preparing such a film for pharmaceutical and nutraceutical applications.

Abstract: Provided are therapeutic products in a form of individual doses for consumption by users. A therapeutic product includes a therapeutic portion and a package. The therapeutic portion includes one or more parts of a plant and may be compressed and formed into an individual dose. The therapeutic product further includes a fibrous portion that includes one or more further parts of the plant. The fibrous portion is structurally attached to the therapeutic portion to form the individual dose of the therapeutic product. The package accommodates the therapeutic portion and the fibrous portion acting as a structural substrate, or the therapeutic portion alone without the fibrous portion.

Abstract: The disclosure relates to methods, systems and compositions for producing emulated honey. More specifically, the disclosure relates to systems, compositions and methods for semi-continuously producing emulated honey using pressure-driven fluidic platforms comprising a plurality of microfluidic and/or milifluidic devices containing fluidic unit operations operable to convert plant nectar to emulated honey.

Abstract: A method of treating skin is disclosed. The method can include topically applying to a person's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNF? production is inhibited in the skin.

Abstract: The present invention relates to methods of extracting cannabinoids from cannabis. Also provided is a cannabinoid extract produced by the method of the invention. In one aspect of the present invention, there is provided a method of preparing a cannabinoid extract, the method comprising heating cannabis plant material for an appropriate time and temperature in order to substantially decarboxylate the cannabis plant material; (ii) extracting cannabinoids from the decarboxylated cannabis plant material by the use of solvents; and (iii) infusing lipid with the extracted cannabinoids. In one embodiment, the present invention provides for methods of preparing a cannabinoid-infused lipid composition and products made by such methods. In another embodiment, the methods render the normally unpleasant tasting concentrated cannabis oil flavorless or reduced in unpleasantness.

Abstract: A system and process for extracting cannabinoids from a marijuana or hemp plant, the system and process utilizing an aqueous solution containing one or more biocatalysts which act upon the marijuana or hemp plant matter to create cannabinoids.

Abstract: Disclosed is to provide a composition for skin-whitening or preventing or improving skin wrinkles, comprising a green tea extract which has modified amounts of ingredients. More specifically, the extract and composition according to one aspect of the present disclosure are derived from natural plants that cause less irritation to the skin and are eco-friendly, thus they are safe, and thereby the extract and composition can exhibit excellent effects of effectively inhibiting melanin production and tyrosinase activity and preventing or improving skin whitening, and can exhibit excellent effects of effectively inhibiting the expression of MMP-1 and preventing or improving skin wrinkles.

Abstract: The invention is directed to natural drug compositions comprising turmeric, boswellia and ginger. Methods for the use of the inventive drug compositions in the treatment of inflammatory disorders and melanoma are within the scope of the invention.

Abstract: A cannabinoid composition, comprising a full spectrum extract of a plant of genus cannabis comprising at least 5% by weight cannabigerol, comprising cannabis terpenes and cannabis flavonoids, and substantially without cannabidiol and tetrahydrocannabinol. The composition may be a pharmaceutically acceptable formulation for oral, sublingual, inhaled, vaporized, or smoked administration. The formulation may include absorption or pharmacological enhancers e.g., curcumin, resveratrol, quercitin, piperine and/or N-alkylamides. The composition has anti-inflammatory properties beneficial as a prophylaxis or therapy of symptoms due to SARS-Cov2 infection.

Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.

Abstract: Compositions and methods of manufacturing mineral pitch resin compositions comprising at least one of a cannabinoid, a terpene, a terpenoid, an essential oil and a fatty acid are provided. Such mineral pitch resin compositions may be safely consumed orally, topically or otherwise, and have numerous health benefits.

Abstract: The present invention belongs to the field of medicine, and relates to use of cannabidiol (CBD) in the treatment of pulmonary arterial hypertension. The CBD can be used as the only active ingredient or combined with other active ingredients to prepare a medicament for treating pulmonary arterial hypertension. Specifically, the present invention relates to use of any one selected from (1) to (3) in the preparation of a medicament for treating and/or preventing pulmonary arterial hypertension: (1) CBD, (2) a plant extract containing the CBD; and preferably, the plant extract is a cannabis extract, and (3) a pharmaceutical composition containing the CBD and one or more pharmaceutically acceptable adjuvants. In the present invention, upon experimental researches, it has found that the CBD has the function of inhibiting pulmonary arterial hypertension, and is especially suitable for treating the pulmonary arterial hypertension caused by hypoxemia.

Abstract: Disclosed are compositions and methods for their use that include a combination of escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.